5(S)-HETE
Based on 1 publication(s) in Google Scholar
5(S)-HETE is an endogenous metabolite present in Blood that can be used for the research of Rheumatoid Arthritis, Rhinitis and Asthma.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 98.9%
- CAS No.: 70608-72-9
- 화학식: C20H32O3
- 분자량:320.47
-
보관:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocol
- 순도&문서
- References
-
Help & FAQs
-
HY-107608
Leukotriene B4PROTAC linker -
HY-150084
(±)14,15-Epoxyeicosatrienoic acidProliferation Inducer -
HY-113490
15-KETE -
HY-130675A
15(S)-HEPEAsthma Marker -
HY-130309
(±)8(9)-EpETEEpoxide -
HY-124404A
12(S)-HETEP38 MAPK/ERK Activator -
HY-120954
14,15-EE-5(Z)-E14,15-EET structural analogue -
HY-130140
8,9-DiHETEEster Product -
HY-130060
12(S)-HETrEPlatelet Aggregation Inhibitor -
HY-118332
19(R)-HETEVasodilator -
HY-130138C
5,6-DiHETEAnti-inflammatory Lipid Mediators -
HY-113711
15-OxoEDEEster Product
Publications Citing Use of MedChemExpress (MCE) 5(S)-HETE
MoreAll Endogenous Metabolite Isoforms
More
Biological Activity
제품 설명
IC50 & Target
|
Human Endogenous Metabolite |
In Vitro
Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 70608-72-9
-
Appearance Liquid
-
분자량 320.47
-
화학식 C20H32O3
-
Color Colorless to light yellow
-
SMILES
CCCCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(O)=O
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Solution, -20°C, 2 years
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cell Metab
2026 Jan 9:S1550-4131(25)00546-7. PMID: 41519131
Protocol
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
순도&문서
-
Data Sheet (265 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
5(S)-HETE Related Classifications
HY-113434 Related Classifications
Powered by Bioz